Literature DB >> 12421507

[Prevalence of Bartonella spp. seropositivity in human immunodeficiency virus-infected and non infected intravenous drug abusers].

Antonio J Ramos1, Julio Vargas, Javier Fernández-Rivera, Juan Macías, José A Mira, Juan A Pineda.   

Abstract

BACKGROUND: Serology is an useful tool in the diagnosis of Bartonella spp. infections in human immunodeficiency virus (HIV) seronegative patients. The value of this technique in HIV co-infected individuals is unknown. The aim of this study was to assess the prevalence of Bartonella spp. seropositivity among intravenous drugs abusers (IDA), both HIV-infected and non-infected. PATIENTS AND
METHOD: A retrospective seroepidemiological study was carried out among 241 IDA. One hundred and forty-seven of them were infected with HIV type 1. The titer of serum IgG antibodies against Bartonella spp. were determined.
RESULTS: Thirty-three (14%) individuals were seropositive for Bartonella spp. Nineteen (13%) seropositive cases were found among HIV carriers and 14 (15%) among HIV uninfected people. No relationship between Bartonella spp. seropositivity and the CD4+ cell counts was found when HIV infected patients were analyzed.
CONCLUSIONS: We have found a similar prevalence of Bartonella spp. seropositivity in HIV-infected and non HIV-infected IDA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421507     DOI: 10.1016/s0025-7753(02)73500-8

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  2 in total

1.  Seroprevalence of Bartonella spp. infection in HIV patients in Catalonia, Spain.

Authors:  Immaculada Pons; Isabel Sanfeliu; María Mercedes Nogueras; Montserrat Sala; Manuel Cervantes; M José Amengual; Ferran Segura
Journal:  BMC Infect Dis       Date:  2008-05-01       Impact factor: 3.090

2.  Seroprevalence of Bartonella spp., Coxiella burnetii, and Hantavirus among people who inject drugs in Rio de Janeiro, Brazil: a retrospective assessment of a biobank.

Authors:  Tatiana Rozental; Anamaria Szrajbman Vaz da Silva; Renata Carvalho de Oliveira; Alexsandra Rodrigues de Mendonça Favacho; Maria de Lourdes Aguiar Oliveira; Francisco Inácio Bastos; Elba Regina Sampaio de Lemos
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-07-19       Impact factor: 1.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.